|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Obuch JC and Ahnen DJ: Colorectal cancer:
Genetics is changing everything. Gastroenterol Clin North Am.
45:459–476. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moriyama T, Ohuchida K, Mizumoto K, Yu J,
Sato N, Nabae T, Takahata S, Toma H, Nagai E and Tanaka M:
MicroRNA-21 modulates biological functions of pancreatic cancer
cells including their proliferation, invasion, and chemoresistance.
Mol Cancer Ther. 8:1067–1074. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhaumik D, Scott GK, Schokrpur S, Patil
CK, Campisi J and Benz CC: Expression of microRNA-146 suppresses
NF-kappaB activity with reduction of metastatic potential in breast
cancer cells. Oncogene. 27:5643–5647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu G, Chen D, Li X, Yang K, Wang H and Wu
W: miR-133b regulates the MET proto-oncogene and inhibits the
growth of colorectal cancer cells in vitro and in vivo. Cancer Biol
Ther. 10:190–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Z, Zhang X, Yang Z, Du H, Wu Z, Gong
J, Yan J and Zheng Q: MiR-145 regulates PAK4 via the MAPK pathway
and exhibits an antitumor effect in human colon cells. Biochem
Biophys Res Commun. 427:444–449. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu L, Cai C, Wang X, Liu M, Li X and Tang
H: MicroRNA-142-3p, a new regulator of RAC1, suppresses the
migration and invasion of hepatocellular carcinoma cells. FEBS
Lett. 585:1322–1330. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu C, Yu J, Yu S, Lavker RM, Cai L, Liu
W, Yang K, He X and Chen S: MicroRNA-21 acts as an oncomir through
multiple targets in human hepatocellular carcinoma. J Hepatol.
53:98–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin
P, Lu Y, Li Q and Liu J: MiR-139 inhibits invasion and metastasis
of colorectal cancer by targeting the type I insulin-like growth
factor receptor. Biochem Pharmacol. 84:320–330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu K, Chen G, Qiu Y, Yuan Z, Li H, Yuan X,
Sun J, Xu J, Liang X and Yin P: miR-503-5p confers drug resistance
by targeting PUMA in colorectal carcinoma. Oncotarget.
8:21719–21732. 2017.PubMed/NCBI
|
|
15
|
Pellatt DF, Stevens JR, Wolff RK, Mullany
LE, Herrick JS, Samowitz W and Slattery ML: Expression profiles of
miRNA subsets distinguish human colorectal carcinoma and normal
colonic mucosa. Clin Transl Gastroenterol. 7:e1522016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar
|
|
18
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garcia DM, Baek D, Shin C, Bell GW,
Grimson A and Bartel DP: Weak seed-pairing stability and high
target-site abundance decrease the proficiency of lsy-6 and other
microRNAs. Nat Struct Mol Biol. 18:1139–1146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Grimson A, Farh KK, Johnston WK,
Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting
specificity in mammals: Determinants beyond seed pairing. Mol Cell.
27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jeanes A, Gottardi CJ and Yap AS:
Cadherins and cancer: How does cadherin dysfunction promote tumor
progression? Oncogene. 27:6920–6929. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sarver AL, French AJ, Borralho PM,
Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM,
Boardman LA, Cunningham JM, et al: Human colon cancer profiles show
differential microRNA expression depending on mismatch repair
status and are characteristic of undifferentiated proliferative
states. BMC Cancer. 9:4012009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shu Y, Ye W, Gu YL and Sun P: Blockade of
miR-663b inhibits cell proliferation and induces apoptosis in
osteosarcoma via regulating TP73 expression. Bratisl Lek Listy.
119:41–46. 2018.PubMed/NCBI
|
|
26
|
Du M, Shi D, Yuan L, Li P, Chu H, Qin C,
Yin C, Zhang Z and Wang M: Circulating miR-497 and miR-663b in
plasma are potential novel biomarkers for bladder cancer. Sci Rep.
5:104372015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cai H, An Y, Chen X, Sun D, Chen T, Peng
Y, Zhu F, Jiang Y and He X: Epigenetic inhibition of miR-663b by
long non-coding RNA HOTAIR promotes pancreatic cancer cell
proliferation via up-regulation of insulin-like growth factor 2.
Oncotarget. 7:86857–86870. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang M, Jia M and Yuan K: MicroRNA-663b
promotes cell proliferation and epithelial mesenchymal transition
by directly targeting SMAD7 in nasopharyngeal carcinoma. Exp Ther
Med. 16:3129–3134. 2018.PubMed/NCBI
|
|
29
|
Wang YL, Shen Y, Xu JP, Han K, Zhou Y,
Yang S, Yin JY, Min DL and Hu HY: Pterostilbene suppresses human
endometrial cancer cells in vitro by down-regulating miR-663b. Acta
Pharmacol Sin. 38:1394–1400. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liang S, Zhang N, Deng Y, Chen L, Zhang Y,
Zheng Z, Luo W, Lv Z, Li S and Xu T: miR-663b promotes tumor cell
proliferation, migration and invasion in nasopharyngeal carcinoma
through targeting TUSC2. Exp Ther Med. 14:1095–1103. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cho SG: APC downregulated 1 inhibits
breast cancer cell invasion by inhibiting the canonical WNT
signaling pathway. Oncol Lett. 14:4845–4852. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Esteller M, Sparks A, Toyota M,
Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G,
Sidransky D, Meltzer SJ, et al: Analysis of adenomatous polyposis
coli promoter hypermethylation in human cancer. Cancer Res.
60:4366–4371. 2000.PubMed/NCBI
|
|
33
|
Liu M, Cui LH, Li CC and Zhang L:
Association of APC, GSTP1 and SOCS1 promoter methylation with the
risk of hepatocellular carcinoma: A meta-analysis. Eur J Cancer
Prev. 24:470–483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen Y, Li J, Yu X, Li S, Zhang X, Mo Z
and Hu Y: APC gene hypermethylation and prostate cancer: A
systematic review and meta-analysis. Eur J Hum Genet. 21:929–935.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kinzler KW, Nilbert MC, Su LK, Vogelstein
B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie
D, et al: Identification of FAP locus genes from chromosome 5q21.
Science. 253:661–665. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Beta M, Chitipothu S, Khetan V, Biswas J
and Krishnakumar S: Hypermethylation of adenomatosis polyposis
coli-2 and its tumor suppressor role in retinoblastoma. Curr Eye
Res. 40:719–728. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rahmatpanah FB, Carstens S, Hooshmand SI,
Welsh EC, Sjahputera O, Taylor KH, Bennett LB, Shi H, Davis JW,
Arthur GL, et al: Large-scale analysis of DNA methylation in
chronic lymphocytic leukemia. Epigenomics. 1:39–61. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ying X, Li-ya Q, Feng Z, Yin W and Ji-hong
L: MiR-939 promotes the proliferation of human ovarian cancer cells
by repressing APC2 expression. Biomed Pharmacother. 71:64–69. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nakagawa H, Murata Y, Koyama K, Fujiyama
A, Miyoshi Y, Monden M, Akiyama T and Nakamura Y: Identification of
a brain-specific APC homologue, APCL, and its interaction with
beta-catenin. Cancer Res. 58:5176–5181. 1998.PubMed/NCBI
|
|
40
|
Jarrett CR, Blancato J, Cao T, Bressette
DS, Cepeda M, Young PE, King CR and Byers SW: Human APC2
localization and allelic imbalance. Cancer Res. 61:7978–7984.
2001.PubMed/NCBI
|
|
41
|
Rubinfeld B, Souza B, Albert I, Müller O,
Chamberlain SH, Masiarz FR, Munemitsu S and Polakis P: Association
of the APC gene product with beta-catenin. Science. 262:1731–1734.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Behrens J, von Kries JP, Kühl M, Bruhn L,
Wedlich D, Grosschedl R and Birchmeier W: Functional interaction of
beta-catenin with the transcription factor LEF-1. Nature.
382:638–642. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bustos VH, Ferrarese A, Venerando A, Marin
O, Allende JE and Pinna LA: The first armadillo repeat is involved
in the recognition and regulation of beta-catenin phosphorylation
by protein kinase CK1. Proc Natl Acad Sci USA. 103:19725–19730.
2006. View Article : Google Scholar : PubMed/NCBI
|
